drugset / Trial / NCT06647277
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
NaSingle-groupOpen-labelSupportive care
Summary
FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.
Timeline
- Start
- 2026-07
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Vancomycin | Other / unclassified | — | — |